http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0890571-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e83d93ed02bbd6159e99b5a7796e3686
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-07
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C213-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C219-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C213-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C213-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
filingDate 1998-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2002-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30148f694468e5ee63b3be1f7ad5a027
publicationDate 2002-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0890571-B1
titleOfInvention Process for the preparation of(1S,2R)-1-amino-2-indanol-(R,R)-tartrate methanol solvate
abstract Process for the preparation of (1S,2R)-1-amino-2-indanol-(R,R)-tartrate methanol solvate, in which in a solvent a mixture of enantiomers of cis-1-amino-2-indanol reacts at an elevated temperature with (R,R)-tartaric acid and methanol and in which optically enriched (1S,2R)-1-amino-2-indanol-(R,R)-tartrate methanol solvate crystallizes out, after which the crystals are recovered, the recovery taking place at a temperature between 10 and 50 DEG C in the presence of 0-20 wt.% water relative to the amount of methanol plus solvent, on the understanding that if the reaction mixture is essentially free from water the recovery substantially takes place at a temperature between 30 and 50 DEG C. Preferably the reactants are at least in part contacted with each other at an elevated temperature and only methanol is used as solvent. Preferably the amount of (1S,2R)-1-amino-2-indanol applied is between 0.02 and 0.1 g per ml of solvent. The invention also relates to (1S,2R)-1-amino-2-indanol-(R,R)-tartrate methanol solvate crystals having a particle size larger than 95 mu m, expressed as DÄv, 0.9Ü, in particular those in which the enantiomeric excess of (1S,2R)-1-amino-2-indanol-(R,R)-tartrate relative to (1R,2S)-1-amino-2-indanol-(R,R)-tartrate is higher than 96%, as well as to application of (1S,2R)-1-amino-2-indanol-(R,R)-tartrate methanol solvate in the preparation of AIDS inhibitors, in particular indinavir sulphate.
priorityDate 1997-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9866743
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID232628729
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21133356
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128519272
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21133357
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444305
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID232623471
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57134941
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462355
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226462076
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID232623470
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226526299
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15870238
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128519268
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID232617930
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127836867
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID232617925
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426153
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127962043
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136083124
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69946670
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53841338
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2725045
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135998608
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID139034
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226526300
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69945409
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135934852
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69944163
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID232628734

Total number of triples: 50.